News

FDA Declared Xarelto Lawsuits are still unabated

xarelto-12262016
Written by admin

Xarelto received two ‘black box’ warnings from the FDA regarding the severe risk associated with the drug. The warnings are the strictest warning a product can receive before being pulled completely from the market. Xarelto is associated with serious potential side effects, complications and risks including, brain hemorrhaging, rectal bleeding, intestinal bleeding, blood clots, pulmonary embolism and deep vein thrombosis and in some unfortunate cases death. Despite of the risk associated with drug FDA declared Xarelto is safe. On Oct. 11, 2016, the FDA released its reanalysis of the ROCKET AF clinical trial data and states that the drug is safe and effective for the treatment of atrial fibrillation (AF) heart condition. As per a statement posted in agency’s websites, The Agency has determined that effects on strokes or bleeding, including bleeding in the head, were minimal and the drug is a safe and effective alternative to warfarin in patients with atrial fibrillation.

The U.S. Food and Drug Administration announced the blockbuster blood thinner Xarelto is safe, however the lawsuits are keeps growing. As per a report released by the the Louisiana court, lawsuits against the blockbuster blood-thinning drug manufacturer, Xarelto have now reached 9,000 lawsuits across the country. The lawsuits are in process regarding Xarelto and according to the report all the Xarelto lawsuits will be consolidated for multidistrict litigation. Xarelto (Rivaroxaban) is used for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for extended risk reduction. The drug has a spotty past and involved in several major lawsuits linked with the severe risk associated with the drug. The number of lawsuit filed from all over the nation alleges that the manufacturers Bayer and Janssen knew or should have known of the risks associated with the drug. Many studies reveals that the patient who takes Xarelto had a 15 percent higher chance of death, 65 percent higher chance of brain bleeds and 48 percent increased risk of major brain bleeds.

The drug makers may have reduced the risk of patients dying on Xarelto from uncontrollable bleeding if they had provided stronger warnings and recommended blood monitoring during treatment as a result thousands of lawsuit have been filed. Due to the increasing numbers of lawsuits the United States Judicial Panel on Multidistrict Litigation announced that the Xarelto lawsuits will be consolidated for multidistrict litigation.  Bayer and Janssen Pharmaceuticals failed to adequately warn doctors as well as patients about the adverse effects cause by the life threatening drug Xarelto and the manufacturers were reckless in releasing the drug to market without a corresponding antidote, which can lead Xarelto to cause someone to bleed to death. The FDA Clean Chit to Xarelto will pave the way to increase the drug sales across the globe. In 2018 the company turnover will be $3.68 billion as estimated by the company analyst.

The FDA decision to say Xarelto a safe and effective drug will not likely to stop additional Xarelto adverse effects lawsuits. If you or your love ones are facing fatal complication due to real brad of Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or loss within limited period of time. We look forward to fighting for the rights of our clients. We have an experience attorneys group who evaluate your case free of cost unless we win the case for you. Contact Drugsclaim.com for free case review.

 

 

 

 

 

 

 

 

 

 

 

About the author

admin

Leave a Comment